Adaptive Biotechnologies (ADPT) Other Non-Current Assets (2018 - 2026)

Adaptive Biotechnologies has reported Other Non-Current Assets for 9 years, with the latest figure at $2.7 million in Q1 2026.

• Quarterly Other Non-Current Assets changed 0.07% year-over-year to $2.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.7 million (changed 0.07% YoY) and the FY2025 annual result came in at $1.2 million, down 47.22% from the prior year.
• Other Non-Current Assets rose to $2.7 million in Q1 2026 per ADPT's latest filing, from $1.2 million in the prior quarter.
• Over five years, Other Non-Current Assets peaked at $3.4 million in Q2 2023 and troughed at $778000.0 in Q2 2022.
• A 5-year average of $2.5 million and a median of $2.7 million in 2025 frame the typical range for Other Non-Current Assets.
• The sharpest annual moves came in 2022 and 2023: Other Non-Current Assets tumbled 63.61% in 2022, then soared 330.85% in 2023.
• Over 5 years, Other Non-Current Assets stood at $2.4 million in 2022, then advanced by 22.17% to $2.9 million in 2023, then fell by 22.0% to $2.3 million in 2024, then plunged by 47.22% to $1.2 million in 2025, then surged by 124.44% to $2.7 million in 2026.
• According to Business Quant data, Other Non-Current Assets over the past three periods registered $2.7 million, $1.2 million, and $2.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.